rs735665

This is a regulatory region variant variant in the GRAMD1B gene.

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

chronic lymphocytic leukemia

Allele A
OR 1.62
p 4.0e-39
N 8,400
Large GWAS
European
Allele A
OR 1.64
p 4.0e-24
N 6,938
Large GWAS
European
Allele A
OR 1.52
p 3.0e-12
N 4,866
Large GWAS
European
Allele A
OR 1.45
p 4.0e-12
N 1,943
Large GWAS
European

serum IgM amount

Jonsson S et al. Identification of sequence variants influencing immunoglobulin levels. Nature Genetics 49(8):1182-1191 (2017)
Allele A
OR 0.15
p 1.0e-23
N 14,442
Large GWAS
European

neoplasm of mature B-cells

Allele T
OR 1.81
p 4.0e-9
N 1,431
Large GWAS
European

leukemia

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.20
p 8.0e-20
N 449,666
Major Consortium StudyLarge GWAS
European

lymphocyte count

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.03
p 4.0e-13
N 417,277
Major Consortium StudyLarge GWAS
multi-ancestry

About GRAMD1B

Predicted to enable cholesterol binding activity; cholesterol transfer activity; and phospholipid binding activity. Predicted to be involved in cellular response to cholesterol; cholesterol homeostasis; and intracellular sterol transport. Located in endoplasmic reticulum membrane; endoplasmic reticulum-plasma membrane contact site; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]

View all GRAMD1B variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…